Home » Stocks » ZYXI

Zynex, Inc. (ZYXI)

Stock Price: $13.89 USD -2.85 (-17.03%)
Updated Jul 30, 2021 4:00 PM EDT - Market closed
After-hours: $14.02 +0.13 (0.94%) Jul 30, 7:46 PM
Market Cap 484.02M
Revenue (ttm) 100.78M
Net Income (ttm) 5.22M
Shares Out 34.85M
EPS (ttm) 0.15
PE Ratio 91.99
Forward PE 44.44
Dividend n/a
Dividend Yield n/a
Trading Day July 30
Last Price $13.89
Previous Close $16.74
Change ($) -2.85
Change (%) -17.03%
Day's Open 14.75
Day's Range 13.69 - 16.74
Day's Volume 1,523,502
52-Week Range 12.53 - 22.89

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Zynex Inc. (ZYXI) delivered earnings and revenue surprises of 14.29% and -0.67%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

3 days ago - Zacks Investment Research

Shares of Zynex (NASDAQ:ZYXI) decreased in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were down 11.11% year over year to $0.08, which beat the estim...

3 days ago - Benzinga

ENGLEWOOD, Colo., July 29, 2021 /PRNewswire/ -- 2021 Second Quarter Revenue increased 61% year over year to $31.0 million Orders increased 247% Net income of $2.8 million; Diluted EPS $0.08 Adjusted EBI...

3 days ago - PRNewsWire

ENGLEWOOD, Colo., July 21, 2021 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain man...

1 week ago - PRNewsWire

Zynex Inc. (ZYXI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

2 weeks ago - Zacks Investment Research

ENGLEWOOD, Colo., July 15, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain manag...

2 weeks ago - PRNewsWire

ENGLEWOOD, Colo., July 13, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain man...

2 weeks ago - PRNewsWire

ENGLEWOOD, Colo., July 8, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain mana...

3 weeks ago - PRNewsWire

Zynex Inc. (ZYXI) delivered earnings and revenue surprises of 0.00% and 2.10%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

3 months ago - Zacks Investment Research

ENGLEWOOD, Colo., April 29, 2021 /PRNewswire/ -- 2021 First Quarter Revenue increased 58% year over year to $24.1 million Orders increased 140% Net loss of $0.7 million; GAAP loss per share $0.02 Adjust...

3 months ago - PRNewsWire

ENGLEWOOD, Colo., April 20, 2021 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain ma...

3 months ago - PRNewsWire

ENGLEWOOD, Colo., April 19, 2021 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain ma...

3 months ago - PRNewsWire

ENGLEWOOD, Colo., April 12, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain mana...

3 months ago - PRNewsWire

ENGLEWOOD, Colo., April 9, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain man...

3 months ago - PRNewsWire

ENGLEWOOD, Colo., March 30, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain ma...

4 months ago - PRNewsWire

With the trading day more than halfway over, the broad markets recovered slightly from Thursday's downturn, with the exception of the Dow Jones industrial average.

Other stocks mentioned: ABNB, EDIT, CNP, AGIO, DNLI, PTR, TREE ...
5 months ago - 24/7 Wall Street

Investors are reacting negatively to the company's Q4 results and Q1 outlook.

5 months ago - The Motley Fool

Shares of Zynex (NASDAQ:ZYXI) rose in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share decreased 44.44% over the past year to $0.05, which missed the esti...

5 months ago - Benzinga

ENGLEWOOD, Colo., Feb. 25, 2021 /PRNewswire/ -- 2020 Full Year Revenue increased 76% year over year to $80.1 million Orders increased 96% Net income of $9.1 million; Diluted EPS $0.26 Adjusted EBITDA $1...

5 months ago - PRNewsWire

ENGLEWOOD, Colo., Feb. 18, 2021 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain man...

5 months ago - PRNewsWire

ENGLEWOOD, Colo., Jan. 28, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain man...

6 months ago - PRNewsWire

ENGLEWOOD, Colo., Jan. 14, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain man...

6 months ago - PRNewsWire

ENGLEWOOD, Colo., Jan. 6, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain mana...

6 months ago - PRNewsWire

These three small-cap stocks all turned a profit last quarter and present ample growth potential at bargain prices.

Other stocks mentioned: KOP, RGNX
6 months ago - The Motley Fool

ENGLEWOOD, Colo., Nov. 19, 2020 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain man...

8 months ago - PRNewsWire

ENGLEWOOD, Colo., Nov. 17, 2020 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain man...

8 months ago - PRNewsWire

Zynex, Inc. (ZYXI) CEO Thomas Sandgaard on Q3 2020 Results - Earnings Call Transcript

9 months ago - Seeking Alpha

Shares of Zynex (NASDAQ:ZYXI) decreased 2.79% in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share fell 33.33% year over year to $0.04, which missed the es...

9 months ago - Benzinga

ENGLEWOOD, Colo., Oct. 27, 2020 /PRNewswire/ -- Revenue increased 69% year over year to $20.0 million Orders increased 96% Net income of $1.3 million; Diluted EPS $0.04 Adjusted EBITDA $2.4 million Zyne...

9 months ago - PRNewsWire

Shares have been taken down yet again, on a mild guidance decrease. However, order growth has come back strongly and revenues will follow that.

9 months ago - Seeking Alpha

ENGLEWOOD, Colo., Oct. 23, 2020 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain man...

9 months ago - PRNewsWire

ENGLEWOOD, Colo., Oct. 20, 2020 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain man...

9 months ago - PRNewsWire

The medical technology company's revenue isn't growing as much as hoped.

9 months ago - The Motley Fool

ENGLEWOOD, Co., Oct. 12, 2020 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain managem...

9 months ago - PRNewsWire

Zynex: 'Electric' Growth And Strong Earnings Keep Us Bullish

9 months ago - Seeking Alpha

A Relative Strength Rating upgrade for Zynex shows improving technical performance. Will it continue?

10 months ago - Investors Business Daily

A Relative Strength Rating upgrade for Zynex shows improving technical performance. The post Zynex Shows Market Leadership With Jump To 82 RS Rating appeared first on Investor's Business Daily.

11 months ago - Investors Business Daily

These stocks are much cheaper than they were a few months ago and have great long-term prospects.

Other stocks mentioned: MGNI, ROIC
11 months ago - The Motley Fool

Zynex, Inc. (ZYXI) CEO Thomas Sandgaard on Q2 2020 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Shares of Zynex (NASDAQ:ZYXI) increased 2.65% in after-market trading after the company reported Q2 results.

1 year ago - Benzinga

ENGLEWOOD, Colo., July 28, 2020 /PRNewswire/ -- Zynex, Inc.

1 year ago - PRNewsWire

Zynex's (ZYXI) April orders down approximately 35% from the January and February average. This may have impacted its Q2 earnings.

1 year ago - Zacks Investment Research

There’s a lot to like about investing in the healthcare sector, so get to know three stocks that make great investments right now.

Other stocks mentioned: IDXX, SMLR
1 year ago - The Motley Fool

The company announced the pricing of a public offering of common stock.

1 year ago - The Motley Fool

ENGLEWOOD, Colo., July 14, 2020 /PRNewswire/ -- Zynex, Inc. ("Zynex") (Nasdaq: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for ...

1 year ago - PRNewsWire

ENGLEWOOD, Colo., July 14, 2020 /PRNewswire/ -- Zynex, Inc. ("Zynex") (Nasdaq: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for ...

1 year ago - PRNewsWire

The company expects strong second-quarter financial results.

1 year ago - The Motley Fool

ENGLEWOOD, Colo., July 9, 2020 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain manage...

1 year ago - PRNewsWire

This selection of growth stocks includes some surprise choices and companies set to benefit from the lasting effects of the pandemic.

Other stocks mentioned: ACLS, FORM, LOGI, TNK, VIVO, ZM
1 year ago - InvestorPlace

Zynex climbed to record highs on Thursday, but there are reasons to pump the brakes on this medical equipment company.

1 year ago - The Motley Fool

About ZYXI

Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. It offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation (TENS), and neuromuscular electrical stimulation (NMES) device; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary inco... [Read more...]

Industry
Medical Devices
Founded
1996
Stock Exchange
NASDAQ
Ticker Symbol
ZYXI
Full Company Profile

Financial Performance

In 2020, Zynex's revenue was $80.12 million, an increase of 76.20% compared to the previous year's $45.47 million. Earnings were $9.07 million, a decrease of -4.40%.

Financial Statements

Analyst Forecasts

According to 5 analysts, the average rating for Zynex stock is "Strong Buy." The 12-month stock price forecast is 26.70, which is an increase of 92.22% from the latest price.

Price Target
$26.70
(92.22% upside)
Analyst Consensus: Strong Buy